250 related articles for article (PubMed ID: 33546113)
1. Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy.
Vassos N; Jakob J; Kähler G; Reichardt P; Marx A; Dimitrakopoulou-Strauss A; Rathmann N; Wardelmann E; Hohenberger P
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546113
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib.
Ramaswamy A; Jain D; Sahu A; Ghosh J; Prasad P; Deodhar K; Shetty N; Banavali S; Shrikhande S; Ostwal V
J Gastrointest Oncol; 2016 Aug; 7(4):624-31. PubMed ID: 27563454
[TBL] [Abstract][Full Text] [Related]
3. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
Qi J; Liu HL; Ren F; Liu S; Shi W; Liu WH; Cai GQ; Liao GQ
World J Surg Oncol; 2020 Apr; 18(1):70. PubMed ID: 32264886
[TBL] [Abstract][Full Text] [Related]
4. Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up.
Lin JX; Chen QF; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM
J Cancer Res Clin Oncol; 2017 Apr; 143(4):727-734. PubMed ID: 28083710
[TBL] [Abstract][Full Text] [Related]
5. Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome.
Wang SY; Wu CE; Lai CC; Chen JS; Tsai CY; Cheng CT; Yeh TS; Yeh CN
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30934606
[TBL] [Abstract][Full Text] [Related]
6. Rectal GIST-Outcomes and viewpoint from a tertiary cancer center.
Zanwar S; Ostwal V; Sahu A; Jain D; Ramaswamy A; Saklani A; Ramadwar M; Shetty N; Shrikande SV
Indian J Gastroenterol; 2016 Nov; 35(6):445-449. PubMed ID: 27783353
[TBL] [Abstract][Full Text] [Related]
7. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: A single-center analysis.
Wang J; Yin Y; Shen C; Yin X; Cai Z; Pu L; Fu W; Wang Y; Zhang B
Medicine (Baltimore); 2020 Feb; 99(9):e19275. PubMed ID: 32118738
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three cases.
Oh JS; Lee JL; Kim MJ; Ryu MH; Chang HM; Kim TW; Jang SJ; Yook JH; Oh ST; Kim BS; Kang YK
Cancer Res Treat; 2006; 38(3):178-83. PubMed ID: 19771279
[TBL] [Abstract][Full Text] [Related]
9. Advanced and Metastatic Gastrointestinal Stromal Tumors Presenting With Surgical Emergencies Managed With Surgical Resection: A Case Series.
Jayant D; Goyal M; Thakur V; Sahu S; Babu B; Subbiah Nagaraj S; Tandup C; Behera A
Cureus; 2024 Feb; 16(2):e53851. PubMed ID: 38465042
[TBL] [Abstract][Full Text] [Related]
10. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
Eisenberg BL; Harris J; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M
J Surg Oncol; 2009 Jan; 99(1):42-7. PubMed ID: 18942073
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
[No Abstract] [Full Text] [Related]
13. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
14. Organ-preserving surgery for locally advanced duodenal gastrointestinal stromal tumor after neoadjuvant treatment.
Lv A; Qian H; Qiu H; Wu J; Li Y; Li Z; Hao C
Biosci Trends; 2017 Sep; 11(4):483-489. PubMed ID: 28845017
[TBL] [Abstract][Full Text] [Related]
15. Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.
Brown JB; Pai RK; Burgess MA; Chennat J; Zureikat AH
J Natl Compr Canc Netw; 2018 Dec; 16(12):1424-1428. PubMed ID: 30545989
[TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors (GIST) of the stomach: retrospective experience with surgical resection at the National Cancer Institute.
Naguib SF; Zaghloul AS; El Marakby H
J Egypt Natl Canc Inst; 2008 Mar; 20(1):80-9. PubMed ID: 19847285
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic resection of locally advanced gastrointestinal stromal tumour (GIST) of the stomach following neoadjuvant imatinib chemoreduction.
Berney CR
Int J Surg Case Rep; 2015; 8C():103-6. PubMed ID: 25651537
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.
Raut CP; Espat NJ; Maki RG; Araujo DM; Trent J; Williams TF; Purkayastha DD; DeMatteo RP
JAMA Oncol; 2018 Dec; 4(12):e184060. PubMed ID: 30383140
[TBL] [Abstract][Full Text] [Related]
20. Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial.
Doyon C; Sidéris L; Leblanc G; Leclerc YE; Boudreau D; Dubé P
Int J Surg Oncol; 2012; 2012():761576. PubMed ID: 23316352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
